ML18068A037
| ML18068A037 | |
| Person / Time | |
|---|---|
| Site: | 03037572 |
| Issue date: | 02/28/2018 |
| From: | Geoffrey Warren NRC/RGN-III |
| To: | Kritzman M Capital Cardiology, PC |
| References | |
| IR 2018001 | |
| Download: ML18068A037 (2) | |
See also: IR 07200201/1980001
Text
NRC FORM 591M PART 1 U.S. NUCLEAR REGULATORY
COMMISSION
(07-2012)
1ocFR2.201
SAFETY INSPECTION
REPORT AND COMPLIANCE
INSPECTION
1. LICENSEE/LOCATION
INSPECTED:
Capital Cardiology, P.C. 1200 E. Michigan Ave. Lansing, Michigan 48912 REPORT NUMBER(S)
2018001 3. DOCKET NUMBER(S)
030-37572
LICENSEE:
2. NRC/REGIONAL
OFFICE Region III U. S. Nuclear Regulatory
Commission
2443 Warrenville
Road, Suite 210 Lisle, IL 60532-4352
4. LICENSE NUMBER(S)
5. DATE(S) OF INSPECTION
21-32677-01
The inspection
was an examination
of the activities
conducted
under your license as they relate to radiation
safety and to compliance
with the Nuclear Regulatory
Commission (NRC) rules and regulations
and the conditions
of your license. The inspection
consisted
of selective
examinations
of procedures
and representative
records, interviews
with personnel, and observations
by the inspector.
The inspection
findings are as follows: Based on the inspection
findings, no violations
were identified.
D 2. Previous violation(s)
closed. D 3. D4. The violations(s), specifically
described
to you by the inspector
as non-cited
violations, are not being cited because they were self-identified, non-repetitive, and corrective
action was or is being taken, and the remaining
criteria in the NRC Enforcement
Policy, to exercise discretiol), were satisfied.
Non-cited
violation(s)
were discussed
involving
the following
requirement(s):
During this inspection, certain of your activities, as described
below and/or attached, were in violation
of NRC requirements
and are being cited in accordance
with NRC Enforcement
Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance
with 10 CFR 19.11. (Violations
and Corrective
Actions) Statement
of Corrective
Actions I hereby state that, within 30 days, the actions described
by me to the Inspector
will be taken to correct the violations
identified.
This statement
of corrective
actions is made in accordance
with the requirements
of 10 CFR 2.201 (corrective
steps already taken, corrective
steps which will be taken, date when full compliance
will be achieved).
I understand
that no further written response to NRC will be required, unless specifically
requested.
TITLE PRINTED NAME SIGNATURE
DATE LICENSEE'S
REPRESENTATIVE
NRC INSPECTOR
Geoffrey Warren, Sr. HP BRANCH CHIEF Aaron Mccraw NRC FORM 591M PART 1 (07-2012)
hV-
NRC FORM 591M PART 3 (07-2012)
10 CFR 2.201 U.S. NUCLEAR REGULATORY
COMMISSION
Docket File Information
SAFETY INSPECTION
REPORT AND COMPLIANCE
INSPECTION
1. LICENSEE/LOCATION
INSPECTED:
Capital Cardiology, P.C. 1200 E. Michigan Ave. Lansing, Michigan
48912 REPORT NUMBER(S)
2018001 3. DOCKET NUMBER(S)
030-37572
6. INSPECTION
PROCEDURES
USED 87130 2. NRG/REGIONAL
OFFICE Region III U. S. Nuclear Regulatory
Commission
2443 Warrenville
Road, Suite 210 Lisle, IL 60532:.4352
4. LICENSE NUMBER(S)
21-32677-01
7. INSPECTION
FOCUS AREAS 03.01 -03.09 5. DATE(S) OF INSPECTION
February 28, 2018 SUPPLEMENTAL
INSPECTION
INFORMATION
1. PROGRAM CODE(S) 02201 2. PRIORITY 5 I{] Main Office Inspection
D Field Office Inspection
D Temporary
Job Site Inspection
3. LICENSEE CONTACT 4. TELEPHONE
NUMBER Michelle Kritzman, M.S., RSO (734) 637-2408 Next Inspection
Date: 02/28/2023
PROGRAM SCOPE This was an unannounced
routine inspection.
The licensee was a cardiology
clinic located in Lansing, Michigan, with authorization
to use byproduct
materials
in 10 CPR 35.200 only. The nuclear medicine department
was staffed with one full-time
nuclear medicine technologist, who typically
administered
120 diagnostic
doses monthly, limited to cardiac stress tests. The department received
unit doses as needed from a licensed nuclear pharmacy.
All waste was either held for decay-in-storage (DIS) or returned to the nuclear pharmacy.
Performance
Observations:
The inspector
observed one diagnostic
administration
of licensed materials, including
dose preparation
and disposal.
The technologist
demonstrated
survey meter and wipe counter QC, dose calibrator
constancy, package receipt surveys and wipes, daily and weekly contamination
surveys, and other procedures.
The inspector
noted no concerns with these activities.
Review of dosimetry
records indicated
no exposures
of regulatory
concern. Interviews
with licensee personnel
indicated
adequate knowledge
of radiation
safety concepts and procedures.
The inspector
performed
independent
and confirmatory
radiation
measurements
which indicated
results consistent
with licensee survey records and postings.
No violations
were identified
during this inspection.
NRG FORM 591M PART 3 (07-2012)